Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
After almost a decade on antiretroviral therapy, half of study participants still had HIV in immune cells in their brain and spinal fluid.
Previous research has shown that long interruptions are not safe—but what about shorter, more closely monitored gaps in treatment?
A third of mice treated with gene editing technique plus long-acting antiretrovirals showed no remaining traces of HIV.
The circumstances of this case are so highly unique, the prospect of replicating it are quite uncertain.
The increasing mastery over the virus is one of humanity’s crowning achievements.
Any HIV cure on the horizon will have to tackle macrophage immune cells as well as CD4 T Cells, a study indicates.
Interfering with this receptor on immune cells could have harmful health consequences.
This finding may eventually make HIV gene therapies more affordable and accessible.
On long-term survival, connecting to the kid in me and why I think Stranger Things is TOTALLY and obviously about HIV.
Women make up half of the HIV population, but the virus affects them differently than men.
A second man’s virus went into remission following an HIV-resistant stem cell transplant to treat his cancer.
A new, more accurate HIV reservoir test is a big advance for cure research.
The amfAR funding goes to scientists using nanotechnology and protein “fingerprinting.”
An all-female panel of amfAR-funded HIV scientists share insights on sex differences in the HIV reservoir, gender in research and more.
One avenue in the HIV cure research field involves using agents that prevent reactivation of HIV replication in latently infected cells.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.